Alaunos Therapeutics Inc (TCRT)
1.11
-0.05
(-4.31%)
USD |
NASDAQ |
May 20, 16:00
1.13
+0.02
(+1.80%)
After-Hours: 20:00
Alaunos Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 1.503M |
September 30, 2023 | 0.001M |
June 30, 2023 | -0.135M |
March 31, 2023 | -0.023M |
December 31, 2022 | -0.093M |
September 30, 2022 | -0.014M |
June 30, 2022 | -0.057M |
March 31, 2022 | -0.029M |
December 31, 2021 | -0.359M |
September 30, 2021 | -0.37M |
June 30, 2021 | -1.877M |
March 31, 2021 | -0.717M |
December 31, 2020 | -3.766M |
September 30, 2020 | -2.012M |
June 30, 2020 | -3.487M |
March 31, 2020 | -0.513M |
December 31, 2019 | -0.10M |
September 30, 2019 | -0.107M |
June 30, 2019 | -0.067M |
March 31, 2019 | -0.01M |
December 31, 2018 | 0.086M |
September 30, 2018 | -0.169M |
June 30, 2018 | -0.226M |
March 31, 2018 | -0.15M |
Date | Value |
---|---|
December 31, 2017 | -0.276M |
September 30, 2017 | -0.076M |
June 30, 2017 | -0.027M |
March 31, 2017 | -0.358M |
December 31, 2016 | -0.082M |
September 30, 2016 | -0.212M |
June 30, 2016 | -0.10M |
March 31, 2016 | -0.157M |
December 31, 2015 | -0.387M |
September 30, 2015 | -0.003M |
June 30, 2015 | -0.005M |
March 31, 2015 | -0.017M |
December 31, 2014 | 0.00 |
September 30, 2014 | -0.094M |
June 30, 2014 | -0.097M |
March 31, 2014 | -0.002M |
December 31, 2013 | -0.013M |
September 30, 2013 | -0.003M |
June 30, 2013 | -0.001M |
March 31, 2013 | -0.114M |
December 31, 2012 | -0.077M |
September 30, 2012 | -0.375M |
June 30, 2012 | -0.953M |
March 31, 2012 | -0.154M |
December 31, 2011 | -0.35M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.766M
Minimum
Dec 2020
1.503M
Maximum
Dec 2023
-0.6111M
Average
-0.1035M
Median
Cash from Investing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 1.00M |
Theriva Biologics Inc | 0.00 |
Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.917M |
Free Cash Flow | -22.68M |
Free Cash Flow Per Share (Quarterly) | -0.1197 |
Free Cash Flow to Equity (Quarterly) | -1.917M |
Free Cash Flow Yield | -127.7% |